Fractional Excretion of Nitric Oxide as a Marker of Response to Reslizumab

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search